Stock Scorecard
Stock Summary for ATAI Life Sciences N.V. (ATAI) - $4.05 as of 8/13/2025 8:25:36 PM EST
Total Score
8 out of 30
Safety Score
-11 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ATAI
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ATAI
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ATAI
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ATAI
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for ATAI (-11 out of 100)
Stock Price Rating (Max of 10) | 3 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 10 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -40 |
Latest News for for ATAI
Financial Details for ATAI
Company Overview |
|
---|---|
Ticker | ATAI |
Company Name | ATAI Life Sciences N.V. |
Country | USA |
Description | ATA Creativity Global provides educational services to students in China. The company is headquartered in Beijing, China. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 3/31/2025 |
Next Earnings Date | 8/18/2025 |
Stock Price History |
|
Last Day Price | 4.05 |
Price 4 Years Ago | 7.63 |
Last Day Price Updated | 8/13/2025 8:25:36 PM EST |
Last Day Volume | 4,384,817 |
Average Daily Volume | 8,020,504 |
52-Week High | 4.40 |
52-Week Low | 1.03 |
Last Price to 52 Week Low | 293.20% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 43.11 |
Sector PE | 57.42 |
5-Year Average PE | -4.95 |
Free Cash Flow Ratio | 17.61 |
Industry Free Cash Flow Ratio | 16.50 |
Sector Free Cash Flow Ratio | 30.31 |
Current Ratio Most Recent Quarter | 4.07 |
Total Cash Per Share | 0.23 |
Book Value Per Share Most Recent Quarter | 0.76 |
Price to Book Ratio | 5.76 |
Industry Price to Book Ratio | 34.22 |
Sector Price to Book Ratio | 28.40 |
Price to Sales Ratio Twelve Trailing Months | 470.29 |
Industry Price to Sales Ratio Twelve Trailing Months | 107.50 |
Sector Price to Sales Ratio Twelve Trailing Months | 32.19 |
Analyst Buy Ratings | 6 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 212,144,000 |
Market Capitalization | 859,183,200 |
Institutional Ownership | 31.30% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -96.80% |
Annual Earnings Growth | -271.09% |
Reported EPS 12 Trailing Months | -0.91 |
Reported EPS Past Year | -0.15 |
Reported EPS Prior Year | -0.93 |
Net Income Twelve Trailing Months | -148,987,000 |
Net Income Past Year | -149,269,000 |
Net Income Prior Year | -40,224,000 |
Quarterly Revenue Growth YOY | -54.00% |
5-Year Revenue Growth | -75.27% |
Operating Margin Twelve Trailing Months | -1,239.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 48,287,000 |
Total Cash Past Year | 17,505,000 |
Total Cash Prior Year | 45,034,000 |
Net Cash Position Most Recent Quarter | 38,987,000 |
Net Cash Position Past Year | 3,372,000 |
Long Term Debt Past Year | 14,133,000 |
Long Term Debt Prior Year | 17,877,000 |
Total Debt Most Recent Quarter | 9,300,000 |
Equity to Debt Ratio Past Year | 0.89 |
Equity to Debt Ratio Most Recent Quarter | 0.94 |
Total Stockholder Equity Past Year | 116,297,000 |
Total Stockholder Equity Prior Year | 242,962,000 |
Total Stockholder Equity Most Recent Quarter | 152,053,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -78,063,020 |
Free Cash Flow Per Share Twelve Trailing Months | -0.37 |
Free Cash Flow Past Year | -82,532,000 |
Free Cash Flow Prior Year | -84,708,000 |
Options |
|
Put/Call Ratio | 0.03 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.40 |
MACD Signal | 0.38 |
20-Day Bollinger Lower Band | 0.53 |
20-Day Bollinger Middle Band | 2.41 |
20-Day Bollinger Upper Band | 4.28 |
Beta | 1.55 |
RSI | 63.98 |
50-Day SMA | 1.81 |
150-Day SMA | 1.84 |
200-Day SMA | 2.97 |
System |
|
Modified | 8/13/2025 5:59:41 PM EST |